Mrs. Amanda Gammel James, PCPNP Pediatrics Medicare: Medicare Enrolled Practice Location: 431 W Lafayette St, Winnfield, LA 71483 Phone: 318-648-0375 |
Alfonso Pacheco, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Hwy 560 Gum Spring Rd, Winn Correctional Center, Winnfield, LA 71438 Phone: 318-628-3971 |
Dr. Jennette Sepulvado Bergstedt, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 431 W Lafayette St, Winnfield, LA 71483 Phone: 318-648-0375 Fax: 318-648-0378 |
News Archive
Today is International Human Rights Day, commemorating the 61st anniversary of the Universal Declaration of Human Rights which states (in Article 26): "Everyone has the right to education [and] education shall be free, at least in the elementary and fundamental stages."
Compugen Ltd. announced today that it has signed a collaboration agreement with Pfizer for the predictive discovery by Compugen of therapeutic peptide product candidates for three drug targets of interest to Pfizer. The discovery process, which will be based on various Compugen discovery platforms and funded by Pfizer, is expected to take a few months, following which the predicted molecules will be synthesized and delivered to Pfizer.
Nevada Cancer Institute has selected Sprint as its wireless communications provider of choice at its new, state-of-the-art facility near Las Vegas. This is the first Sprint in-building coverage and capacity agreement involving a large healthcare institution in the Las Vegas market.
Tibet Pharmaceuticals, Inc., an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, today announced the availability of the transcript for its second quarter 2011 earnings conference call, held on August 16th.
BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
› Verified 2 days ago